Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target
Key Takeaways
- The selected price target is $11 per share, the highest current analyst target and a level just above the stock's 52-week high of $10.05.
- Butterfly Network has delivered record quarterly revenue, raised its full-year guidance, and holds a "Strong Buy" consensus, the strongest bullish factors supporting further upside.
- The company remains unprofitable with high research and development spending, a key obstacle to sustained appreciation.
- The $10.05 level represents a critical resistance zone that would need to be cleared before $11 becomes attainable.
- The key takeaway: reaching $11 is plausible but depends on continued revenue growth and execution rather than on momentum alone.
Why This Price Level Stands Out
Butterfly Network, Inc. (BFLY) develops handheld ultrasound systems built on proprietary ultrasound-on-chip technology. Its point-of-care devices focus on portability and affordability for clinicians. Recent expansions include software and platform offerings such as the Butterfly Embedded program and the Butterfly Garden AI marketplace.
The $11 target matters because it sits just above the 52-week high of $10.05 and aligns with the most bullish analyst forecast. It also represents a roughly 15% gain from recent levels near $9.50, offering a clear benchmark without appearing overly distant.
Current Market Position
The stock has recovered sharply from its 52-week low of $1.34, driven by improved sentiment around the platform transition and better fundamentals. In the second quarter, Butterfly Network posted record revenue of approximately $32.6 million and raised its full-year 2026 outlook to a range of roughly $119 million to $123 million. Analysts project continued double-digit revenue growth into 2027.
Wall Street’s consensus rating stands at “Strong Buy,” with average 12-month price targets ranging from $9.31 to $10.50 depending on the source. Individual targets span from about $5.25 on the low side to $11 on the high end, highlighting differing views on the pace of scaling and profitability.
Potential Drivers for Further Gains
Several developments could support a move toward $11. A co-development and licensing agreement with Midjourney delivered a $15 million upfront fee plus ongoing annual license revenue, adding a software-style income stream. Management has emphasized Butterfly Embedded for integration into third-party devices and the Butterfly Garden ecosystem for partner-developed, FDA-cleared AI applications.
Government opportunities via FedRAMP certification could open doors with agencies such as the Department of Veterans Affairs. The Home & Community Care initiative, aimed at at-home monitoring for conditions like congestive heart failure, offers another long-term avenue. Sustained revenue beats and progress on these newer segments would provide the fundamental backing needed for higher prices. I also checked comparable setups using Tickeron’s AI Screener to see how the stock stacks up against peers.
Obstacles That Could Limit Upside
Profitability remains the primary challenge. Butterfly Network continues to report net losses and negative earnings per share, with elevated research and development costs pressuring results. Because the stock trades mainly on growth expectations, any revenue slowdown, delayed enterprise deals, or guidance miss could weigh on the valuation.
Some independent models suggest the shares trade modestly above estimated fair value, implying that optimistic scenarios may already be priced in. The spread in analyst targets reflects this uncertainty, with several firms maintaining targets of $6 or lower.
Key Technical Levels to Watch
From a technical standpoint, the $10.05 area serves as the main resistance level. A decisive break above it would be necessary for the $11 target to come into realistic reach. On the downside, the $9 psychological level and the broader $8 zone have acted as support where buyers have stepped in previously. Holding above $9 would help maintain the longer-term recovery trend.
Monitoring Momentum with AI Signals
In my analysis of BFLY and similar names, I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to track shifting momentum across thousands of stocks and ETFs. The tool applies artificial intelligence to market conditions and technical behavior, delivering Buy, Sell, or Hold signals that help identify emerging trends without constant manual chart review.
Final Assessment
A move to $11 for Butterfly Network looks ambitious yet attainable given the stock’s position only about 15% below that level, its Strong Buy consensus, record revenue, raised guidance, and expanding platform strategy. These elements provide legitimate support for further appreciation.
That said, the path is not guaranteed. The company is still unprofitable, valuation appears elevated to some models, and the stock must first clear the $10.05 resistance. Investors should track quarterly revenue growth, movement toward profitability, commercialization of the Embedded and Garden platforms, and whether prices hold above key support zones. Reaching $11 will likely hinge on steady execution across these areas.
Using Tickeron for Ongoing Research
Traders looking to follow BFLY alongside other opportunities can explore Tickeron’s AI Daily Buy/Sell Signals for structured, AI-driven insights into momentum and trend shifts. I find it helpful for staying objective when evaluating resistance levels and entry points.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BFLY's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for BFLY turned positive on August 03, 2026. Looking at past instances where BFLY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on BFLY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 155 cases where BFLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where BFLY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BFLY broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.423) is normal, around the industry mean (11.035). P/E Ratio (0.000) is within average values for comparable stocks, (70.949). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.006). BFLY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (21.786) is also within normal values, averaging (34.463).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MedicalNursingServices
Advertisement